Last 61,500 KRW
Change Today +600.00 / 0.99%
Volume 73.7K
006120 On Other Exchanges
Symbol
Exchange
Korea SE
Korea SE
As of 1:10 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

sk chemicals co ltd (006120) Snapshot

Open
61,300
Previous Close
60,900
Day High
62,400
Day Low
60,500
52 Week High
08/28/14 - 69,700
52 Week Low
01/3/14 - 51,800
Market Cap
1.3T
Average Volume 10 Days
98.5K
EPS TTM
-333.00
Shares Outstanding
20.8M
EX-Date
12/27/13
P/E TM
--
Dividend
400.00
Dividend Yield
0.65%
Current Stock Chart for SK CHEMICALS CO LTD (006120)

Related News

No related news articles were found.

sk chemicals co ltd (006120) Related Businessweek News

No Related Businessweek News Found

sk chemicals co ltd (006120) Details

SK Chemicals Co., Ltd. is engaged in chemical and life science businesses in Korea and internationally. The company provides copolyester comprising bio copolyester products under the ECOZEN name; SKYGREEN PETG resins; and polyethylene terephthalate resins under the SKYPET name. It also offers polyester resins for the use in coil and can coating under the SKYBON name; chemicals, reagents, and solvents that are used in laboratory research, electric/electronics, and bio-technology industry under the CnR name; chemicals, such as optical materials for display technology and electrolytes for supercapacitors; and acoustic insulations under the SKYVIVA name. In addition, the company provides non-hazardous sound absorbing/proofing material for automotive applications under the SKYNOVA name; sheet materials under the SKYFLEX name; and engineering plastic products under the SK COMPOUND and ECOTRAN names. Further, it offers biomaterial products comprising biodiesel under the ECOPRIME name; and polylactic acid biomaterial products under the ECOPLAN name. Additionally, the company provides prescription medicines primarily for fibrous tumors, prostates, endometriosis, and diabetes diseases; OTC products for blood circulation, anti-inflammatory and analgesic actions, arthritis, muscle pain, and bruises; and medical IT solutions. It also offers vaccines for hepatitis B; chickenpox; diphtheria, tetanus, and pertussis; polio; measles, mumps, and rubella; tetanus and diphtheria; and eningitis and influenza, as well as operates in consulting, polyester adhesives manufacturing, pharmaceutical marketing, and plastic material wholesale businesses. SK Chemicals Co., Ltd. was founded in 1969 and is headquartered in Seongnam, South Korea.

Founded in 1969

sk chemicals co ltd (006120) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sk chemicals co ltd (006120) Key Developments

Sanofi Pasteur SA Partners with SK Chemicals Ltd to Co-Develop Pneumococcal Conjugate Vaccine

Sanofi Pasteur SA has signed an agreement with SK Chemicals Co. Ltd., to co-develop a pneumococcal conjugate vaccine. The collaboration agreement includes research and development, production and commercialization of a preventative pneumococcal disease vaccine. As part of the agreement, Sanofi will make an up-front payment of $23 million to SK Chemicals. Both companies will co-invest in the development of the PCV vaccine project and, if successful, SK Chemicals would produce the vaccine at its production facility located in An-dong--the southern part of Korea. The product, once registered, will be launched globally by Sanofi Pasteur with shared profits outside of Korea, where SK Chemicals would commercialize it with exclusive rights.

Teijin and SK Chemicals to Building a New Polyphenylene Sulphide Resins Plant in Ulsan

Teijin and SK Chemicals are jointly building a new polyphenylene sulphide (PPS) resins plant in Ulsan. Construction of the 12,000 tonnes/year PPS resin plant at Ulsan began on 1 October 2013. A joint venture firm called INITZ Co was set up - in which Teijin holds a 34% stake and SK Chemicals a 66% stake - for the project to develop and sell PPS resins and compounds.

Breckenridge Pharmaceutical, Inc. Signs Letter of Intent with Welding GmbH & CO. KG and SK Chemicals Ltd

Breckenridge Pharmaceutical, Inc. announced that it has entered into a Development Agreement with Welding GmbH & CO. KG and SK Chemicals Ltd. to develop and market an ANDA with U.S. branded sales of approximately $500 million. Under the terms of this agreement, Welding and SK will develop and manufacture the product, utilizing SK's advanced drug delivery system, for Breckenridge Pharmaceutical, Inc., who will have exclusive marketing and distribution rights in the U.S. This agreement further supports Breckenridge's interest in leveraging drug delivery technologies to diversify its product development pipeline.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
006120:KS 61,500.00 KRW +600.00

006120 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celanese Corp $59.49 USD +0.90
Daicel Corp ¥1,420 JPY +24.00
Mitsui Chemicals Inc ¥334.00 JPY +7.00
STR Holdings Inc $1.31 USD -0.02
View Industry Companies
 

Industry Analysis

006120

Industry Average

Valuation 006120 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.8x
Price/Cash Flow 56.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SK CHEMICALS CO LTD, please visit www.skchemicals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.